Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Multicenter Confirmatory Clinical Evaluation of Novilase® Interstitial Laser Therapy for the Focal Destruction of Malignant Breast Tumors ≤15 mm (BR-003)

NCT03463954 is registered in ClinicalTrials.gov with Novian Health Inc. as lead sponsor.

NCT NCT03463954
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03463954 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Multicenter Confirmatory Clinical Evaluation of Novilase® Interstitial Laser Therapy for the Focal Destruction of Malignant Breast Tumors ≤15 mm (BR-003)
Lead sponsor
Novian Health Inc.
Phase
Not applicable
Overall status
Recruiting
Start date
August 9, 2023
Completion date
March 30, 2027
Enrollment
122 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

malignant neoplasm of breast